Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care

BMC Family Practice

Study Protocol

Corinne H Stoop¹  François Pouwer¹  Victor JM Pop¹  Viola RM Spek¹ 

[1] Department of Medical Psychology & Neuropsychology, Center of Research on Psychology in Somatic diseases (CoRPS), Tilburg University, Tilburg, The Netherlands;

关键词: diabetes;    depression;    anxiety;    primary care;    study protocol;    randomised controlled trial;    disease management;    stepped care;    psychological intervention;   

DOI  :  10.1186/1471-2296-12-139

 received in 2011-11-03, accepted in 2011-12-15,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundDepression and anxiety are common co-morbid health problems in patients with type 2 diabetes. Both depression and anxiety are associated with poor glycaemic control and increased risk of poor vascular outcomes and higher mortality rates. Results of previous studies have shown that in clinical practice, treatment of depression and anxiety is far from optimal as these symptoms are frequently overlooked and undertreated.Methods/DesignThis randomised controlled trial will examine the effectiveness of a disease management programme treating symptoms of depression and anxiety in primary care patients with Type 2 diabetes. Patients will be randomized on patient level in 1:1 ratio. Random block sizes of 2 and 4 are used. The disease management programme consists of screening, stepped treatment and monitoring of symptoms (n = 80). This will be compared to care as usual (n = 80).DiscussionThe disease management model for co-morbid depression and anxiety in primary care patients with diabetes is expected to result in reduced symptoms of depression and anxiety, improved quality of life, reduced diabetes specific distress and improved glyceamic control, compared to care as usual.Trial RegistrationDutch Trial Register NTR2626

【 授权许可】

Unknown   
© Stoop et al; licensee BioMed Central Ltd. 2011. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.